Thermoregulation - Comprehensive Notes
Learning objectives and key terms
Key terms to know: thermoregulation, hypothalamus, thermoreceptors, thermo effectors, vasodilation, vasoconstriction, thermogenesis, shivering thermogenesis, non shivering thermogenesis, normothermia, hyperthermia, hypothermia, pyrexia, pyrogens, cytokines.
What is thermoregulation?
The process by which the body maintains its core temperature within a healthy range.
The hypothalamus acts as the body's thermostat, regulating the set point of body temperature by receiving input from peripheral and central thermoreceptors and comparing to the target range.
Normal thermia (core temperature) is defined in this class as approximately , which corresponds to .
Fever is defined as a core temperature greater than (≈ ).
This provides a broad overview of thermoregulation pathophysiology.
Heat flow and thermoregulation basics
Heat transfer principle: heat flows from warmer to cooler areas; the body uses regulated mechanisms to maintain core temperature as environment changes.
Thermoregulation begins with thermoreceptors: specialized sensory nerve endings detecting temperature changes.
Peripheral thermoreceptors (skin) sense external temperature.
Central thermoreceptors (hypothalamus) monitor core body temperature.
When a change is detected, thermoreceptors signal the hypothalamus, which then activates thermo effectors to conserve or release heat as needed.
Core temperature balance is actively maintained because chemical reactions, enzyme activity, and immune functions depend on a stable core temperature.
Mechanisms: hypothalamic control and thermo effectors
The hypothalamus serves as the control center: always compares current temperature to the set point range.
If temperature deviates from the set point, the hypothalamus activates thermo effectors to restore homeostasis.
Heat loss responses (when temperature is high):
Sweating promotes cooling via evaporation.
Vasodilation widens blood vessels to increase heat loss.
Heat gain responses (when temperature is low):
Vasoconstriction reduces heat loss by limiting peripheral blood flow.
Shivering generates heat through involuntary skeletal muscle contractions.
Non shivering thermogenesis (metabolic heat production) occurs, especially important in infants.
These processes work together to maintain stable core function, as chemical reactions, enzyme activity, and immune functions require a stable core temperature.
Heat transfer mechanisms in more detail
Conduction: direct heat transfer between molecules; example: heat transfer from body to a cooler surface.
E.g., placing a cold washcloth on a fever patient transfers heat away by conduction.
Convection: heat transfer via moving air or fluids; a thin layer of warm air remains near the skin, which is replaced by cooler ambient air to facilitate cooling.
Radiation: heat transfer via infrared electromagnetic waves; can occur through air or empty space. The sun warming the Earth is a natural example.
At typical room temperature, an unclothed person can lose up to of body heat via radiation.
Newborns are particularly susceptible to rapid radiative heat loss.
Evaporation: cooling by turning water on the skin into vapor; includes insensible perspiration (through skin) and sweating (through sweat glands).
Insensible perspiration occurs especially in dry environments.
Evaporative cooling is effective when the external environment is hotter than the skin.
Heat gain mechanisms from environment include conduction, convection, and radiation as heat sources when external temps are higher than skin/core temps.
If evaporation is interrupted, heat cannot be efficiently removed, leading to a rise in core temperature.
Role of vasomotor and pilomotor responses
Vasoconstriction: constricts blood vessels to conserve heat and maintain core temperature; can cause pallor as blood is shunted toward the core.
Piloerection (goosebumps): contraction of pilomotor muscles around hair follicles traps a layer of air to reduce heat loss; more effective in fur-bearing animals than humans.
Vasodilation: widening of blood vessels to increase heat loss when overheated.
Other autonomic responses include changes in heart rate and metabolism to support thermoregulation.
Thermogenesis and metabolic heat production
Heat production (thermogenesis) is driven by metabolism and changes in neurohormonal signals.
Increased basal metabolic rate (BMR) leads to higher heat production.
Mechanisms include increased release of:
Epinephrine and norepinephrine
Thyroid hormones: T3 (triiodothyronine) and T4 (thyroxine)
Brown fat non shivering thermogenesis is especially important in infants; brown adipose tissue metabolizes fat to generate heat.
In infants, brown fat is used because they cannot effectively shiver yet; premature infants have less brown fat and are more susceptible to rapid heat loss.
Oxygen consumption increases with higher metabolic rate; in babies, cooling can reduce oxygen saturation, so temperature monitoring is critical.
Practical neonatal care: swaddling, head coverings, incubators, and internal heat sources help regulate infant temperature.
Population vulnerability and practical considerations
Vulnerable populations include:
Individuals under the influence of drugs or alcohol (reduced awareness, impaired shivering or sweating, poor temperature judgment).
Homeless or impoverished individuals with limited access to shelter, clothing, or heating/cooling.
Those with cognitive impairments (e.g., dementia) may not recognize or respond appropriately to extremes.
Neonates, especially preterm or low birth weight, with underdeveloped thermoregulatory systems and high surface area-to-volume ratio.
People with certain medical conditions (hypothyroidism, cardiovascular, cerebrovascular disease, spinal cord injury).
Athletes in extreme environments (ice/snow, water sports, exertion) who may overwhelm thermoregulation.
Exemplars of thermoregulation disorders
Hypothermia: core temperature < (95°F).
Definition: mild to profound heat loss with compromised core temperature regulation.
Common causes: prolonged cold exposure, inadequate clothing, wet conditions, and some medical conditions (e.g., hypothyroidism).
At-risk populations: elderly, infants, those with chronic illnesses, and environmental factors (extreme weather, lack of shelter).
Subtypes include environmental, accidental, and perioperative hypothermia (e.g., due to anesthesia lowering metabolic rate and warming thresholds).
Pathophysiology: when heat loss exceeds heat production, core temperature drops; compensatory mechanisms include peripheral vasoconstriction and shivering; prolonged hypothermia leads to hypoxia, metabolic acidosis, and tissue damage; severe hypothermia can cause bradycardia, hypotension, multi-organ failure, and death if not corrected.
Fever (pyrexia): a temporary rise in body temperature due to illness, infection, inflammation, or immune challenges.
Fever threshold in this course: core temperature > (100.4°F).
Hypothalamic set point is raised by pyrogens, triggering heat-producing and heat-conserving responses.
Hyperthermia: rise in body temperature greater than (101°F) without a change in the hypothalamic set point.
Causes include excessive heat production, high environmental temperatures, or inability to release heat effectively.
Conditions: heat stress, heat exhaustion, heat stroke; certain drug reactions can also cause hyperthermia.
Distinction from fever: fever involves a hypothalamic set point change; hyperthermia is a failure of heat-regulation mechanisms without a changed set point.
Fever in more detail: mechanisms and stages
Pyrogens trigger fever by causing the hypothalamus to raise the set point.
Exogenous pyrogens: from outside the body (e.g., bacteria, viruses, pathogens).
Endogenous pyrogens: produced within the body (e.g., cytokines).
Cytokines involved: interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α).
These cytokines stimulate the production of prostaglandin E2 (PGE2), which acts on the hypothalamus to increase the set point.
Systemic responses accompany fever: leukocytosis, anorexia, malaise.
Fever can occur in non-infectious conditions as well (e.g., myocardial infarction, pulmonary embolism, surgical trauma, some cancers).
Four stages of fever (not always all stages occur):
1) Prodrome (onset): nonspecific symptoms like headache, fatigue, malaise, myalgias.
2) Chill phase (rigors): temperature rises to meet the new set point; patient feels cold, shivering; skin may be pale due to vasoconstriction.
3) Flush (plateau) phase: set point reached; shivering stops; skin becomes warm and flushed; tachycardia and increased respiration; thirst and dehydration may occur; appetite decreases.
4) Defervescence (fever breaks): diaphoresis (profuse sweating); flushed warm skin; fatigue.
Hyperthermia details and management
Hyperthermia stages and signs: heat stress, heat exhaustion, heat stroke.
Heat stress/early stage: heat production exceeds dissipation; symptoms include cramps, sweating, flushed skin, fatigue, weakness, tachycardia, tachypnea.
Heat exhaustion (moderate hyperthermia): core temperature may exceed (101°F); symptoms include diaphoresis, thirst, nausea, vomiting, dizziness, oliguria, weakness, altered consciousness.
Heat stroke (severe hyperthermia): core temperature > (104°F); dry skin (sweating may stop), confusion or agitation, tachypnea, hypotension, tachycardia, seizures, loss of consciousness; risk of multi-organ failure.
Malignant hyperthermia: a life-threatening hypermetabolic crisis in patients with a genetic RYR1 mutation affecting calcium handling in skeletal muscle.
Triggers: inhaled volatile anesthetics and/or depolarizing neuromuscular blocker like succinylcholine.
Mechanism: abnormal Ca2+ release → sustained muscle contraction → increased O2 consumption, CO2 production, lactic acidosis, hyperthermia, rhabdomyolysis, hyperkalemia.
Stages: prodromal rise in end-tidal CO2 and muscle rigidity; progressive hypermetabolism with rapid temperature rise (> ); eventual complications including dysrhythmias, DIC, and organ failure.
Treatment: stop triggers, administer dantrolene, initiate cooling and provide oxygenation and ventilation support.
Management of hyperthermia depends on stage and symptoms, not solely temperature; cooling, hydration, electrolyte management, and treating underlying cause.
Therapeutic hypothermia and targeted temperature management (TTM)
Therapeutic hypothermia (targeted temperature management) is used to reduce ischemic injury in cardiac arrest, perioperative contexts, cerebral ischemia, and neonatal hypoxic-ischemic injury.
Target range: typically (89.6–96.8°F).
Induction phase: cooling rate of about to reach target temperature within roughly 4–8 hours.
Cooling methods: ice-cold IV fluids, cooling blankets, ice packs, cooling device systems, and specialized closed-loop catheter systems for rapid blood cooling via femoral venous access.
Maintenance phase: keep within the target temperature for at least 24 hours.
Rewarming phase: rewarm slowly, typically (0.45–0.9°F/hour); gradual rewarming to avoid hemodynamic instability and afterdrop.
Risks and monitoring: same risks as accidental hypothermia; require careful monitoring of cardiopulmonary status and electrolyte balance.
Hypothermia in clinical progression and management
Mild hypothermia (32–35° C): sympathetic activation predominates; shivering and vasoconstriction are effective; signs include hypertension, tachycardia, shivering, hyperventilation, cyanosis, agitation, mild disorientation.
Moderate hypothermia (28–32° C): shivering may cease due to energy depletion; thermogenesis declines; signs include hypotension, shallow respirations, cardiac dysrhythmias, muscle rigidity, delirium, decreased consciousness, metabolic acidosis.
Severe/profound hypothermia (<28° C): cardiovascular collapse may occur; peripheral pulses may be weak or absent; vasoconstriction and high blood viscosity impair perfusion; signs include unconsciousness, fixed/dilated pupils, severe dysrhythmias, absent reflexes, edema, metabolic disturbances, and potential long-term neurological injury.
Prolonged hypothermia can cause hypoxia, metabolic acidosis, tissue damage, organ failure, and death if not corrected.
Treatment approach depends on severity and includes passive (warm blankets, dry clothing, heated environment) and active rewarming (heated IV fluids, warmed humidified oxygen, external warming devices, and in severe cases core rewarming via invasive methods or ECMO).
Rewarming goals: restore core temperature safely without causing afterdrop; continuous monitoring of rhythm, vital signs, and core temperature.
Frostbite vs frostnip: cold exposure injuries to skin and tissue with varying degrees of involvement; managed with rewarming, protection, analgesia, and possibly surgical intervention if necrosis occurs.
Frostbite and frostnip
Frostnip: early, reversible stage with erythema, tingling, or numbness.
Superficial frostbite: skin appears white, waxy, pale; firm to touch but soft beneath.
Deep frostbite: skin turns blue/purple; hard, cold, and numb with loss of sensation; possible tissue necrosis.
Treatment: rewarming, protecting the skin, pain management, and surgical interventions if tissue necrosis develops.
Practical/clinical implications and ethical considerations
Recognize that thermoregulation is affected by physiology, environment, medications, and underlying disease.
Vulnerable populations require proactive temperature monitoring and protective strategies in extreme environments or during perioperative care.
When managing fever, distinguish between fever (set point elevation) and hyperthermia (thermoregulatory failure without set point change) to guide treatment.
Fever management must consider underlying cause; antipyretics (e.g., acetaminophen, ibuprofen) alleviate symptoms but do not treat the underlying cause of pyrexia.
In hypothermia, staged rewarming and monitoring reduce risk of complications like arrhythmias, acidosis, and tissue damage; avoid rapid heating of extremities to prevent afterdrop.
In neonates and prematurity, passive strategies (swaddling, hats, incubators) support thermoregulation, while non-shivering thermogenesis via brown fat helps generate heat.
In malignant hyperthermia, rapid identification and treatment with dantrolene can be life-saving; avoidance of triggering agents is critical.
Ethical considerations include balancing temperature management with quality of life, potential adverse effects of therapies, and timely escalation of care in severe cases (e.g., ECMO in profound hypothermia).
Quick reference: key numerical values and formulas
Normal core temperature:
Fever threshold: T_{core} > 38^\circ C \quad (> 100.4^\circ F)
Therapeutic hypothermia (TTM):
Induction cooling rate:
Maintenance duration: at least
Rewarming rate:
Radiation heat loss (approximate): up to of total heat loss in typical room conditions
Heat transfer modes: conduction, convection, radiation, evaporation
PGE2 mechanism: cytokines IL-1 and TNF-α stimulate PGE2 production, which acts on the hypothalamus to raise the set point
Endpoints to monitor in hypothermia/TTM: cardiac rhythm, vital signs, core temperature, oxygenation, and hemodynamics
Summary takeaway
Thermoregulation is a dynamic, integrative process governed by the hypothalamus to maintain a stable core temperature via multiple neural, hormonal, and metabolic pathways.
Understanding the differences between fever and hyperthermia, and recognizing hypothermia’s stages, informs appropriate treatment strategies and monitoring requirements.
Advanced therapies like therapeutic hypothermia and malignant hyperthermia management require precise timing, monitoring, and access to specific interventions (e.g., dantrolene, ECMO) to optimize outcomes.